Federal Register / Vol. 66, No. 43 / Monday, March 5, 2001 / Notices 13327

recommendations to the agency on

FDA’s regulatory issues.

Date and Time: The meeting will be

held on March 15, 2001, from 8:30 a.m.

to 6 p.m. and on March 16, 2001, from

8:30 a.m. to 12 noon.

Location: Hilton, 620 Perry Pkwy.,

Gaithersburg, MD.

Contact: Linda A. Smallwood, Center

for Biologics Evaluation and Research

(HFM–302), Food and Drug

Administration, 1401 Rockville Pike,

Rockville, MD 20852–1448, 301–827–

3514, or FDA Advisory Committee

Information Line, 1–800–741–8138

(301–443–0572 in the Washington, DC

area), code 19516. Please call the

Information Line for up-to-date

information on this meeting.

Agenda: On March 15, 2001, the

committee will hear presentations,

discuss and make recommendations on

the comparative sensitivity of Hepatitis

B Virus nucleic acid testing versus

Hepatitis B Surface Antigen testing. In

the afternoon, the committee will hear

presentations, discuss and make

recommendations on the

implementation of nucleic acid testing

for Hepatitis C Virus and human

immunodeficiency virus, testing donor

and product management, and blood

bags for diversion of the initial

collection. On March 16, 2001, the

committee will hear updates on the

following topics: (1) Summaries of the

Transmissible Spongiform

Encephalopathies Advisory Committee

Meeting and the Public Health Service

Advisory Committee Meeting on blood

safety and availability, and (2) The

Office of Inspector General’s report on

tissue and organ regulation. The

committee will additionally hear

presentations, discuss and make

recommendations on the topic of

guidance on malaria, applicability to

plasma.

Procedure: On March 15, 2001, from

8:30 a.m. to 6 p.m. and on March 16,

2001, from 8:30 a.m. to 12 noon, the

meeting is open to the public. Interested

persons may present data, information,

or views, orally or in writing, on issues

pending before the committee. Written

submissions may be made to the contact

person by March 9, 2001. Oral

presentations from the public will be

scheduled between approximately 9:30

a.m. and 10:30 a.m., 1:30 p.m. and 2:30

p.m., and 4:30 p.m. and 5:30 p.m. on

March 15, 2001, and 10:15 a.m. and

10:30 a.m. on March 16, 2001. Time

allotted for each presentation may be

limited. Those desiring to make formal

oral presentations should notify the

contact person before March 9, 2001,

and submit a brief statement of the

general nature of the evidence or

arguments they wish to present, the

names and addresses of proposed

participants, and an indication of the

approximate time requested to make

their presentation.

FDA regrets that it was unable to

publish this notice 15 days prior to the

March 15 to 16, 2001, Blood Products

Advisory Committee meeting. Because

the agency believes there is some

urgency to bring these issues to public

discussion and qualified members of the

Blood Products Advisory Committee

were available at this time, the

Commissioner of Food and Drugs

concluded that it was in the public

interest to hold this meeting even if

there was not sufficient time for the

customary 15-day public notice.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: February 28, 2001.

Linda A. Suydam,

Senior Associate Commissioner.

[FR Doc. 01–5375 Filed 3–1–01; 11:53 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–1728]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: Revision of a currently

approved collection; Title of

Information Collection: Home Health

Agency Cost Report and Supporting

Regulations in 42 CFR 413.20, 413.24

and 413.106; Form No.: HCFA–1728

(OMB No. 0938–0022); Use:

Participating providers are required to

submit annual information to HCFA in

order to achieve settlement of costs for

health care services rendered to

Medicare beneficiaries. The HCFA–1728

is the form used by Home Health

Agencies to report their health care

costs to determine the amount

reimbursable for services furnished to

Medicare beneficiaries; Frequency:

Annually; Affected Public: Business or

other for profit, Not for profit

institutions, and State, Local or Tribal

Gov.; Number of Respondents: 7,310;

Total Annual Responses: 7,310; Total

Annual Hours Requested: 1,293,870.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, access HCFA’s Web

Site address at http://www.hcfa.gov/

regs/prdact95.htm, or E-mail your

request, including your address, phone

number, OMB number, and HCFA

document identifier, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 30 days of this notice directly to

the OMB desk officer: OMB Human

Resources and Housing Branch,

Attention: Wendy Taylor, New

Executive Office Building, Room 10235,

Washington, D.C. 20503.

Dated: February 15, 2001.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA Office

of Information Services, Security and

Standards Group, Division of HCFA

Enterprise Standards.

[FR Doc. 01–5181 Filed 3–2–01; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–R–108]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the